Medicine
Dextrose and Heparin 5 g/4000 units per 100 mL injection
Dextrose and Heparin 5 g/4000 units per 100 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Dextrose and Heparin
- Brand
- Sold under the generic name
- Strength
- 5 g/4000 units per 100 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 24 containers
- Manufacturer
- B. Braun Medical
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 July 1992
- Identifiers
- DailyMed set ID 92a6f533-1a3d-4734-b413-d245592454e3NDC 0264-9567Application NDA019952
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 container in 1 case / 500 mL in 1 container | 0264-9567-10 | B. Braun Medical | 20 July 1992 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dextrose and Heparin
Clinical summary
Dextrose and Heparin is a fixed-dose combination of an anti-coagulant and an unfractionated heparin. It is available as injection for intravenous use. MedsAcross supplies Dextrose and Heparin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Dextrose and HeparinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Heparin Sodium in Dextrose prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Dextrose and Heparin 5 g/4000 units per 100 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.